The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Identification of predictive and pharmacodynamic biomarkers associated with the first-in-class selective axl inhibitor bemcentinib across multiple phase II clinical trials.
 
Robert J Holt
Employment - BerGenBio
Patents, Royalties, Other Intellectual Property - BerGenBio
 
David Micklem
Employment - BerGenBio
Leadership - BerGenBio
Stock and Other Ownership Interests - BerGenBio
Patents, Royalties, Other Intellectual Property - BerGenBio
 
Anthony Brown
Employment - BerGenBio
Stock and Other Ownership Interests - BerGenBio
 
Murray Yule
Employment - BerGenBio
Leadership - BerGenBio
Stock and Other Ownership Interests - BerGenBio
 
Sonja Loges
No Relationships to Disclose
 
James Lorens
Employment - BerGenBio
Leadership - BerGenBio
Stock and Other Ownership Interests - BerGenBio
Research Funding - BerGenBio
Patents, Royalties, Other Intellectual Property - BerGenBio (Inst)
Travel, Accommodations, Expenses - BerGenBio